Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Paul Dockerty

Paul Dockerty

Customer Engagement Manager – Professional Services

Connect with Paul Dockerty on LinkedIn
Website:

About the author: Dr. Paul Dockerty has a Pharmacist degree from the University of Rouen, France, a M.S degree in Chemistry from the University Paris Descartes, France and a Ph.D in Chemical Biology from the University of Groningen, The Netherlands where he focused on the development of chemical probes based on a enol-carbamate scaffold. He works now as a Customer Engagement Manager in the Professional Services group at Elsevier and is responsible for supporting pharmaceutical customers in their digitalization journey.

Posts by Paul Dockerty

Exploiting similarities between SARS-CoV-2 and other viruses to accelerate vaccine and therapy development

Posted on April 17th, 2020 in COVID-19

Coronavirus disease 19 (COVID-19) is now present in 230 countries, areas or territories around the world. As of April 15, 2020, the World Health Organization has reported 117,021 deaths [1]. Researchers across the globe are collaborating to develop antivirals and vaccines. In this context, understanding the vast amount of data published on SARS-CoV and other viruses is key to tackling the challenge of containing the 2019 novel coronavirus (SARS-CoV-2).

(more…)

  1. 1
  2. 2